A New Series of IDO1 Inhibitors Derived from Microbial Metabolites
Phytochemistry letters(2023)
摘要
Indoleamine 2,3-dioxygenase 1 (IDO1) is a rate-limiting enzyme catalyzing the metabolism of tryptophan along the kynurenine pathway, which has an effect on tumor immune escape, depression, inflammation, and neuro-degenerative disease. Thus, IDO1 has become a promising therapeutic target in disease treatment, and IDO1 inhibitors have attracted much attention. In this study, we discovered a series of IDO1 inhibitors through high-throughput screening. The compounds belonged to angucyclinones. Compound 1 exhibited potent IDO1 inhi-bition in both enzymatic and cellular assays with IC50 values of 0.230 mu M and 2.100 mu M, respectively. Enzyme kinetics experiments revealed that Compound 1 was a reversible and uncompetitive inhibitor of IDO1. Furthermore, Compound 1 significantly reduced plasma kynurenine levels in a mouse model. This study iden-tified potential IDO1 inhibitors for the development of new therapies in the treatment of multiple diseases.
更多查看译文
关键词
IDO1 inhibitors,High throughput screening,Microbial metabolites,Disease treatment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要